References

• • Parkinson Study Group (2002) A Controlled Trial of Rasagiline in Early Parkinson Dise...
• • Parkinson Study Group (2005) A Randomized Placebo-Controlled Trial of Rasagiline in L...
• • Rascol, O., Brooks, D.J., Melamed, E., et al. (2005) Rasagiline as an Adjunct to Levo...
• • Olanow, C.W., Rascol, O., Hauser, R., et al. (2009) A Double-Blind, Delayed-Start Tri...
• • Hattori, N., Takeda, A., Takeda, S., et al. (2018) Rasagiline Monotherapy in Early Pa...
• • Sandoval-Rincon, M., Saenz-Farret, M., Miguel-Puga, A., Micheli, F. and Arias-Carrion...
• • Hanagasi, H.A., Gurvit, H., Unsalan, P., et al. (2011) The Effects of Rasagiline on C...
• • Blandini, F., Armentero, M.T., Fancellu, R., Blaugrund, E. and Nappi, G. (2004) Neuro...
• • Sagi, Y., Mandel, S., Amit, T. and Youdim, M.B. (2007) Activation of Tyrosine Kinase ...
• • Spottke, A.E., Reuter, M., Machat, O., et al. (2005) Cost of Illness and Its Predicto...
• • Winter, Y., von Campenhausen, S., Reese, J.P., et al. (2010) Costs of Parkinson’s Dis...
• • Hensler, K., Uhlmann, C., Porschen, T., Benecke, R. and Rosche, J. (2013) Generic Sub...
• • European Medicines Agency (2010) Guideline on the Investigation of Bioequivalence. Lo...
• • US Food and Drug Administration (2003) Guidance for Industry: Bioavailability and Bio...
• • Raw, A.S., Lionberger, R. and Yu, L.X. (2011) Pharmaceutical Equivalence by Design fo...
• • van der Meersch, A., Dechartres, A. and Ravaud, P. (2011) Quality of Reporting of Bio...
• • Bosnyak, E., Herceg, M., Pal, E., et al. (2014) Are Branded and Generic Extended-Rele...
• • Martinez-Martin, P., Rojo-Abuin, J.M., Rodriguez-Violante, M., et al. (2016) Analysis...
• • Go, C.L., Rosales, R.L., Schmidt, P., Lyons, K.E., Pahwa, R. and Okun, M.S. (2011) Ge...
• • Pahwa, R.P.R., Lyons, K.E., Majama, J., McGuire, D., Koller, W., Silverstein, P., et ...
• • Pahwa, R., Marjama, J., McGuire, D., et al. (1996) Pharmacokinetic Comparison of Sine...
• • Hauser, R.A., Olanow, C.W. and Koller, W.C. (1994) Time Course of Washout of Symptoma...
• • Nutt, J.G., Carter, J.H. and Woodward, W.R. (1995) Long-Duration Response to Levodopa...
• • Kasemsap, N., Onsanit, S., Chiewthanakul, P., et al. (2016) Efficacy and Motor Compli...
• • Zhang, Z., Shao, M., Chen, S., et al. (2018) Adjunct Rasagiline to Treat Parkinson’s ...
• • Martinez-Martin, P., Forjaz, M.J., Cubo, E., Frades, B., de Pedro Cuesta, J. and Memb...
• • Arnold, G., Gasser, T., Storch, A., et al. (2005) High Doses of Pergolide Improve Cli...
• • Takanashi, M., Shimo, Y., Hatano, T., Oyama, G. and Hattori, N. (2013) Efficacy and S...
• • Drossman, D.A., Camilleri, M., Mayer, E.A. and Whitehead, W.E. (2002) AGA Technical R...
• • Peery, A.F., Dellon, E.S., Lund, J., et al. (2012) Burden of Gastrointestinal Disease...
• • Mearin, F., Lacy, B.E., Chang, L., Longstreth, G.F., Thompson, W.G., Chey, W.D., et a...
• • Ford, A.C., Moayyedi, P., Lacy, B.E., et al. (2014) American College of Gastroenterol...
• • Drossman, D.A., Chey, W.D., Johanson, J.F., et al. (2009) Clinical Trial: Lubiproston...
• • Pimentel, M., Lembo, A., Chey, W.D., et al. (2011) Rifaximin Therapy for Patients wit...
• • Lembo, A.J., Lacy, B.E., Zuckerman, M.J., et al. (2016) Eluxadoline for Irritable Bow...
• • Tornblom, H., Lindberg, G., Nyberg, B. and Veress, B. (2002) Full-Thickness Biopsy of...
• • Chadwick, V.S., Chen, W., Shu, D., et al. (2002) Activation of the Mucosal Immune Sys...
• • Guilarte, M., Santos, J., de Torres, I., et al. (2007) Diarrhoea-Predominant IBS Pati...
• • Dinan, T.G., Quigley, E.M., Ahmed, S.M., et al. (2006) Hypothalamic-Pituitary-Gut Axi...
• • Bueno, L. (2008) Protease Activated Receptor 2: A New Target for IBS Treatment. Europ...